“…Such storage is not restricted to critically ill patients, but widespread in both healthy volunteers and surgical patients (Bellmann, Feistritzer et al, 2012;Wiedermann and Joannidis, 2014). Secondly, the occurrence of HES-induced coagulopathy is well-established (Hartog, Reuter et al, 2011) and is likely to negatively affect clinical outcome at least in certain settings (Navickis, Haynes et al, 2012;Haase, Wetterslev et al, 2013;Rasmussen, Johansson et al, 2014). Thirdly, beneficial effects with HES beyond intermediate surrogate markers, such as fluid use, have not yet been demonstrated.…”